Royal Bank of Canada
SANA icon

Royal Bank of Canada’s Sana Biotechnology SANA Stock Holding History

Royal Bank of Canada’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35K Buy
12,285
+5,338
+77% +$21K ﹤0.01% 5660
2025
Q4 		$28K Sell
6,947
-579,031
-99% -$2.59M ﹤0.01% 5868
2025
Q3 		$2.08M Buy
585,978
+114,371
+24% +$413K ﹤0.01% 3377
2025
Q2 		$1.29M Buy
471,607
+468,933
+17,537% +$968K ﹤0.01% 3677
2025
Q1 		$4K Sell
2,674
-4,318
-62% -$12.1K ﹤0.01% 6428
2024
Q4 		$11K Sell
6,992
-10,818
-61% -$32.3K ﹤0.01% 6324
2024
Q3 		$74K Buy
17,810
+4,975
+39% +$26.1K ﹤0.01% 5517
2024
Q2 		$70K Buy
12,835
+5,766
+82% +$45.9K ﹤0.01% 5490
2024
Q1 		$70K Sell
7,069
-24,419
-78% -$183K ﹤0.01% 5377
2023
Q4 		$129K Buy
31,488
+15,522
+97% +$57.2K ﹤0.01% 5457
2023
Q3 		$61K Buy
15,966
+6,229
+64% +$33.5K ﹤0.01% 5675
2023
Q2 		$58K Buy
9,737
+4,157
+74% +$24K ﹤0.01% 5704
2023
Q1 		$18K Sell
5,580
-6,025
-52% -$24.1K ﹤0.01% 6070
2022
Q4 		$47K Buy
11,605
+10,195
+723% +$49.9K ﹤0.01% 5924
2022
Q3 		$9K Buy
1,410
+559
+66% +$4.03K ﹤0.01% 6483
2022
Q2 		$5K Sell
851
-4,754
-85% -$30.3K ﹤0.01% 6666
2022
Q1 		$46K Sell
5,605
-14,877
-73% -$120K ﹤0.01% 6158
2021
Q4 		$317K Buy
20,482
+10,377
+103% +$200K ﹤0.01% 4879
2021
Q3 		$227K Buy
10,105
+8,066
+396% +$169K ﹤0.01% 5057
2021
Q2 		$40K Buy
2,039
+1,898
+1,346% +$43K ﹤0.01% 6187
2021
Q1 		$5K Buy
+141
New +$4.59K ﹤0.01% 7053

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Royal Bank of Canada's SANA Position: Q1 2026 in Review

Royal Bank of Canada increased its Sana Biotechnology (SANA) stake by 77% in Q1 2026, buying an estimated $21K and bringing the position to 12,285 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #5660.

Royal Bank of Canada first reported a position in SANA in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.08M in Q3 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Royal Bank of Canada held 12,285 shares of Sana Biotechnology worth $35K as of Q1 2026.
  • Royal Bank of Canada bought 5,338 Sana Biotechnology shares in Q1 2026, an estimated $21K.
  • Sana Biotechnology made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5660 holding.
  • Royal Bank of Canada first reported a position in Sana Biotechnology in Q1 2021 and has held it in 21 quarters since.
  • Royal Bank of Canada's Sana Biotechnology position peaked at $2.08M in Q3 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.